During physician focus groups, several practical considerations were raised that were not highlighted when learning from patients. There was a general sense that neither minority patients nor minority physicians receive the same opportunities for research involvement as their white counterparts. Both societal and institutional changes will be required to level the playing field in this regard:

This was also highlighted during the Patient Advisory Council as another element that can lead to mistrust:

Physicians also highlighted a perceived lack of representation within the pharmaceutical industry as being a barrier to achieving equity in clinical research access. With the industry focused on diversity, the situation continues to evolve with the extension of inclusive practices to ensure greater representation:

KEY TAKEAWAY

Proactively engaging with existing sites to support them in accessing a diversity of communities and selecting and partnering with new sites that work with patients from underrepresented backgrounds is an important step to more inclusive clinical research.


Discussions on Diversity Report

Download

Executive Summary

Download